Omnicell (MEX:OMCL) Cyclically Adjusted Revenue per Share: MXN496.99 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:OMCL Omnicell Inc MEX:OMCL
77 GF Score
Price MXN761.16
GF Value MXN843.76
! 6 Warning Signs
View Full Analysis

What is Omnicell Cyclically Adjusted Revenue per Share?

Omnicell MEX:OMCL 77 Cyclically Adjusted Revenue per Share is MXN496.99 as of Jun. 2026. GuruFocus rates MEX:OMCL with a GF Score™ of 77/100 and a GF Value™ of MXN843.76. The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Omnicell's adjusted revenue per share for the three months ended in Jun. 2026 was MXN117.656. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN496.99 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Omnicell's average Cyclically Adjusted Revenue Growth Rate was 5.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Omnicell was 13.90% per year. The lowest was 0.00% per year. And the median was 11.90% per year.

As of today (2026-09-08), Omnicell's current stock price is MXN761.16. Omnicell's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN496.99. Omnicell's Cyclically Adjusted PS Ratio of today is 1.53.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Omnicell was 10.20. The lowest was 1.02. And the median was 3.91.


Omnicell  (MEX:OMCL) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Omnicell's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=761.16/496.99
=1.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Omnicell was 10.20. The lowest was 1.02. And the median was 3.91.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Omnicell Cyclically Adjusted Revenue per Share Related Terms


Omnicell Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Omnicell's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omnicell Cyclically Adjusted Revenue per Share Chart

Omnicell Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 388.42 1,602.37 2,332.65 536.69 557.80

Omnicell Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 842.46 825.72 557.80 771.68 496.99

MEX:OMCL vs SDGR, OMDA, CERT: Cyclically Adjusted Revenue per Share Comparison

For the Health Information Services subindustry, Omnicell's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnicell Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Omnicell's Cyclically Adjusted PS Ratio falls into.


MEX:OMCL
77GF Score
Omnicell Inc MEX:OMCL
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omnicell Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Omnicell's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=117.656/333.9520*333.9520
=117.656

Current CPI (Jun. 2026) = 333.9520.

Omnicell Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 92.163 241.428 127.483
201612 96.688 241.432 133.740
201703 75.926 243.801 104.001
201706 85.288 244.955 116.275
201709 86.960 246.819 117.659
201712 89.585 246.524 121.356
201803 83.589 249.554 111.858
201806 92.683 251.989 122.829
201809 93.510 252.439 123.705
201812 100.125 251.233 133.091
201903 92.912 254.202 122.061
201906 97.247 256.143 126.788
201909 104.921 256.759 136.465
201912 107.938 256.974 140.271
202003 123.465 258.115 159.740
202006 108.012 257.797 139.919
202009 108.050 260.280 138.633
202012 112.613 260.474 144.380
202103 111.026 264.877 139.980
202106 115.254 271.696 141.663
202109 126.076 274.310 153.488
202112 127.136 278.802 152.285
202203 132.480 287.504 153.883
202206 144.116 296.311 162.423
202209 152.801 296.808 171.923
202212 129.889 296.797 146.149
202303 116.706 301.836 129.124
202306 112.719 305.109 123.375
202309 114.100 307.789 123.799
202312 96.572 306.746 105.137
202403 89.329 312.332 95.512
202406 110.148 314.175 117.082
202409 119.778 315.301 126.863
202412 135.657 315.605 143.543
202503 118.399 319.799 123.639
202506 116.440 322.561 120.552
202509 124.145 324.800 127.643
202512 124.316 324.054 128.113
202603 121.628 330.213 123.005
202606 117.656 333.952 117.656

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN496.99 mean?
Omnicell (MEX:OMCL) has a Cyclically Adjusted Revenue per Share of MXN496.99 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Omnicell and its competitors.
Is Omnicell's Cyclically Adjusted Revenue per Share too high?
Omnicell's current Cyclically Adjusted Revenue per Share is MXN496.99. Overall, Omnicell has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Omnicell's Cyclically Adjusted Revenue per Share compare to SDGR and OMDA?
Omnicell's Cyclically Adjusted Revenue per Share of MXN496.99 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Omnicell and its competitors. Omnicell's current Cyclically Adjusted Revenue per Share is MXN496.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omnicell stock overvalued right now?
Omnicell (MEX:OMCL) has a current Cyclically Adjusted Revenue per Share of MXN496.99. The stock's GF Value™ is MXN843.76, compared to a current price of MXN761.16 — trading 9.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN496.99. Omnicell's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Omnicell (MEX:OMCL), the current Cyclically Adjusted Revenue per Share is MXN496.99 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omnicell (MEX:OMCL) Overvalued in 2026?

Based on GuruFocus' analysis, Omnicell stock appears to be undervalued. The current stock price of MXN761.16 is trading 9.8% below its estimated GF Value™ of MXN843.76.

Key valuation signals for MEX:OMCL:

  • Cyclically Adjusted Revenue per Share: MXN496.99
  • GF Value™: MXN843.76 vs. price of MXN761.16 (9.8% below fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the MEX:OMCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omnicell Business Description

Other Exchanges OMCL:USAOC9:Germany
Address 4220 North Freeway, Fort Worth, TX, USA, 76137
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
77GF Score

Get the complete analysis for MEX:OMCL

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN761.16
Price
MXN843.76
GF Value